Evidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic

dc.creatorDowsett, Mitch
dc.creatorEllis, Matthew J.
dc.creatorDixon, J. Michael
dc.creatorGluz, Oleg
dc.creatorRobertson, John
dc.creatorKates, Ronald
dc.creatorSuman, Vera J.
dc.creatorTurnbull, Arran K.
dc.creatorNitz, Ulrike
dc.creatorChristgen, Matthias
dc.creatorKreipe, Hans
dc.creatorKuemmel, Sherko
dc.creatorBliss, Judith M.
dc.creatorBarry, Peter
dc.creatorJohnston, Stephen R.
dc.creatorJacobs, Samuel A.
dc.creatorMa, Cynthia X.
dc.creatorSmith, Ian E.
dc.creatorHarbeck, Nadia
dc.date.accessioned2020-07-22T16:07:31Z
dc.date.accessioned2022-09-23T18:11:09Z
dc.date.available2020-07-22T16:07:31Z
dc.date.available2022-09-23T18:11:09Z
dc.date.created2020-07-22T16:07:31Z
dc.identifier2374-4677
dc.identifierhttps://www.nature.com/articles/s41523-020-0168-9
dc.identifierhttp://hdl.handle.net/20.500.12010/10942
dc.identifierhttps://doi.org/10.1038/s41523-020-0168-9
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3496997
dc.publisherScience Direct
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourcereponame:Expeditio Repositorio Institucional UJTL
dc.sourceinstname:Universidad de Bogotá Jorge Tadeo Lozano
dc.subjectCáncer
dc.titleEvidence-based guidelines for managing patients with primary ER+ HER2− breast cancer deferred from surgery due to the COVID-19 pandemic


Este ítem pertenece a la siguiente institución